Vaccines program gets $300 mil.
Executive Summary
A total of $300 million in Recovery Act funds will be allocated to the Centers for Disease Control and Prevention Sec. 317 grant program, the main source of funding for state and jurisdictional immunization programs, Vice President Joe Biden announced April 9. Most of the funding will be targeted to programs for making CDC-purchased vaccines available to states and territories. Approximately $18 million in grants will be designated for innovative approaches to increasing immunizations with the childhood vaccine series, zoster vaccine and influenza vaccine, and for improving reimbursement practices
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.